Correlation Between Pasithea Therapeutics and NLS Pharmaceutics
Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and NLS Pharmaceutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and NLS Pharmaceutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pasithea Therapeutics Corp and NLS Pharmaceutics AG, you can compare the effects of market volatilities on Pasithea Therapeutics and NLS Pharmaceutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of NLS Pharmaceutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and NLS Pharmaceutics.
Diversification Opportunities for Pasithea Therapeutics and NLS Pharmaceutics
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Pasithea and NLS is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and NLS Pharmaceutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NLS Pharmaceutics and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with NLS Pharmaceutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NLS Pharmaceutics has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and NLS Pharmaceutics go up and down completely randomly.
Pair Corralation between Pasithea Therapeutics and NLS Pharmaceutics
Given the investment horizon of 90 days Pasithea Therapeutics Corp is expected to under-perform the NLS Pharmaceutics. But the stock apears to be less risky and, when comparing its historical volatility, Pasithea Therapeutics Corp is 1.89 times less risky than NLS Pharmaceutics. The stock trades about -0.25 of its potential returns per unit of risk. The NLS Pharmaceutics AG is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest 411.00 in NLS Pharmaceutics AG on August 29, 2024 and sell it today you would lose (45.00) from holding NLS Pharmaceutics AG or give up 10.95% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pasithea Therapeutics Corp vs. NLS Pharmaceutics AG
Performance |
| Timeline |
| Pasithea Therapeutics |
| NLS Pharmaceutics |
Pasithea Therapeutics and NLS Pharmaceutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pasithea Therapeutics and NLS Pharmaceutics
The main advantage of trading using opposite Pasithea Therapeutics and NLS Pharmaceutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, NLS Pharmaceutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NLS Pharmaceutics will offset losses from the drop in NLS Pharmaceutics' long position.| Pasithea Therapeutics vs. Nutriband Warrant | Pasithea Therapeutics vs. MediciNova | Pasithea Therapeutics vs. Eliem Therapeutics | Pasithea Therapeutics vs. Virax Biolabs Group |
| NLS Pharmaceutics vs. Eliem Therapeutics | NLS Pharmaceutics vs. Scpharmaceuticals | NLS Pharmaceutics vs. Milestone Pharmaceuticals | NLS Pharmaceutics vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |